在 COVID-19 大流行的背景下确定优先次序和资源分配。对德国结直肠癌和胰腺癌的建议。

IF 2 4区 医学 Q3 ONCOLOGY Oncology Research and Treatment Pub Date : 2024-01-01 Epub Date: 2024-03-14 DOI:10.1159/000538171
Celine Lugnier, Sabine Sommerlatte, Ulrike Attenberger, Ambros J Beer, Martin Bentz, Stefan R Benz, Thomas Birkner, Jens Büntzel, Matthias P A Ebert, Peter Fasching, Wolfgang Fischbach, Emmanouil Fokas, Birgit Fricke, Helene Hense, Erich Grohmann, Ralf-Dieter Hofheinz, Dietrich Hüppe, Stefan Huster, Patrick Jahn, Monika Klinkhammer-Schalke, Wolfgang Knauf, Anna-Lena Kraeft, Bernd Oliver Maier, Georg Marckmann, Günter Niegisch, Lutz Otto, Uwe Pelzer, Pompiliu Piso, Henning Rosenau, Jochen Schmitt, Olaf Schoffer, Jalid Sehouli, Andrea Tannapfel, Ulrich Wedding, Simone Wesselmann, Eva C Winkler, Tanja Zimmermann, Bernhard Wörmann, Anke Reinacher-Schick, Jan Schildmann
{"title":"在 COVID-19 大流行的背景下确定优先次序和资源分配。对德国结直肠癌和胰腺癌的建议。","authors":"Celine Lugnier, Sabine Sommerlatte, Ulrike Attenberger, Ambros J Beer, Martin Bentz, Stefan R Benz, Thomas Birkner, Jens Büntzel, Matthias P A Ebert, Peter Fasching, Wolfgang Fischbach, Emmanouil Fokas, Birgit Fricke, Helene Hense, Erich Grohmann, Ralf-Dieter Hofheinz, Dietrich Hüppe, Stefan Huster, Patrick Jahn, Monika Klinkhammer-Schalke, Wolfgang Knauf, Anna-Lena Kraeft, Bernd Oliver Maier, Georg Marckmann, Günter Niegisch, Lutz Otto, Uwe Pelzer, Pompiliu Piso, Henning Rosenau, Jochen Schmitt, Olaf Schoffer, Jalid Sehouli, Andrea Tannapfel, Ulrich Wedding, Simone Wesselmann, Eva C Winkler, Tanja Zimmermann, Bernhard Wörmann, Anke Reinacher-Schick, Jan Schildmann","doi":"10.1159/000538171","DOIUrl":null,"url":null,"abstract":"<p><p>In the context of the COVID-19 pandemic, there has been a scarcity of resources with various effects on the care of cancer patients. This paper provides an English summary of a German guideline on prioritization and resource allocation for colorectal and pancreatic cancer in the context of the pandemic. Based on a selective literature review as well as empirical and ethical analyses, the research team of the CancerCOVID Consortium drafted recommendations for prioritizing diagnostic and treatment measures for both entities. The final version of the guideline received consent from the executive boards of nine societies of the Association of Scientific Medical Societies in Germany (AWMF), 20 further professional organizations and 22 other experts from various disciplines as well as patient representatives. The guiding principle for the prioritization of decisions is the minimization of harm. Prioritization decisions to fulfill this overall goal should be guided by (1) the urgency relevant to avoid or reduce harm, (2) the likelihood of success of the diagnostic or therapeutic measure advised, and (3) the availability of alternative treatment options. In the event of a relevant risk of harm as a result of prioritization, these decisions should be made by means of a team approach. Gender, age, disability, ethnicity, origin, and other social characteristics, such as social or insurance status, as well as the vehemence of a patient's treatment request and SARS-CoV-2 vaccination status should not be used as prioritization criteria. The guideline provides concrete recommendations for (1) diagnostic procedures, (2) surgical procedures for cancer, and (3) systemic treatment and radiotherapy in patients with colorectal or pancreatic cancer within the context of the German healthcare system.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany.\",\"authors\":\"Celine Lugnier, Sabine Sommerlatte, Ulrike Attenberger, Ambros J Beer, Martin Bentz, Stefan R Benz, Thomas Birkner, Jens Büntzel, Matthias P A Ebert, Peter Fasching, Wolfgang Fischbach, Emmanouil Fokas, Birgit Fricke, Helene Hense, Erich Grohmann, Ralf-Dieter Hofheinz, Dietrich Hüppe, Stefan Huster, Patrick Jahn, Monika Klinkhammer-Schalke, Wolfgang Knauf, Anna-Lena Kraeft, Bernd Oliver Maier, Georg Marckmann, Günter Niegisch, Lutz Otto, Uwe Pelzer, Pompiliu Piso, Henning Rosenau, Jochen Schmitt, Olaf Schoffer, Jalid Sehouli, Andrea Tannapfel, Ulrich Wedding, Simone Wesselmann, Eva C Winkler, Tanja Zimmermann, Bernhard Wörmann, Anke Reinacher-Schick, Jan Schildmann\",\"doi\":\"10.1159/000538171\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the context of the COVID-19 pandemic, there has been a scarcity of resources with various effects on the care of cancer patients. This paper provides an English summary of a German guideline on prioritization and resource allocation for colorectal and pancreatic cancer in the context of the pandemic. Based on a selective literature review as well as empirical and ethical analyses, the research team of the CancerCOVID Consortium drafted recommendations for prioritizing diagnostic and treatment measures for both entities. The final version of the guideline received consent from the executive boards of nine societies of the Association of Scientific Medical Societies in Germany (AWMF), 20 further professional organizations and 22 other experts from various disciplines as well as patient representatives. The guiding principle for the prioritization of decisions is the minimization of harm. Prioritization decisions to fulfill this overall goal should be guided by (1) the urgency relevant to avoid or reduce harm, (2) the likelihood of success of the diagnostic or therapeutic measure advised, and (3) the availability of alternative treatment options. In the event of a relevant risk of harm as a result of prioritization, these decisions should be made by means of a team approach. Gender, age, disability, ethnicity, origin, and other social characteristics, such as social or insurance status, as well as the vehemence of a patient's treatment request and SARS-CoV-2 vaccination status should not be used as prioritization criteria. The guideline provides concrete recommendations for (1) diagnostic procedures, (2) surgical procedures for cancer, and (3) systemic treatment and radiotherapy in patients with colorectal or pancreatic cancer within the context of the German healthcare system.</p>\",\"PeriodicalId\":19543,\"journal\":{\"name\":\"Oncology Research and Treatment\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Research and Treatment\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000538171\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000538171","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在 COVID-19 大流行的背景下,资源匮乏对癌症患者的治疗产生了各种影响。本文以英文概述了德国关于大流行病背景下结肠直肠癌和胰腺癌的优先次序和资源分配的指南。根据有选择性的文献综述以及经验和伦理分析,CancerCOVID 联合会的研究团队起草了针对这两种癌症的诊断和治疗措施优先顺序的建议。该指南的最终版本获得了德国科学医学协会(AWMF)9 个协会的执行委员会、20 个其他专业组织、22 位来自不同学科的其他专家以及患者代表的同意。确定优先次序的指导原则是将伤害降至最低。为实现这一总体目标而做出的优先决策应遵循以下原则:1.避免或减少伤害的紧迫性;2.建议的诊断或治疗措施取得成功的可能性;3.是否有替代治疗方案。如果优先顺序的确定会导致相关的伤害风险,则应通过团队方式做出这些决定。性别、年龄、残疾、种族、出身和其他社会特征,如社会或保险状况,以及患者治疗请求的强烈程度和 SARS-CoV-2 疫苗接种状况,都不应作为确定优先次序的标准。在德国医疗保健系统的范围内,该指南为结肠直肠癌或胰腺癌患者的 1.诊断程序、2.癌症手术程序以及 3.系统治疗和放射治疗提供了具体建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany.

In the context of the COVID-19 pandemic, there has been a scarcity of resources with various effects on the care of cancer patients. This paper provides an English summary of a German guideline on prioritization and resource allocation for colorectal and pancreatic cancer in the context of the pandemic. Based on a selective literature review as well as empirical and ethical analyses, the research team of the CancerCOVID Consortium drafted recommendations for prioritizing diagnostic and treatment measures for both entities. The final version of the guideline received consent from the executive boards of nine societies of the Association of Scientific Medical Societies in Germany (AWMF), 20 further professional organizations and 22 other experts from various disciplines as well as patient representatives. The guiding principle for the prioritization of decisions is the minimization of harm. Prioritization decisions to fulfill this overall goal should be guided by (1) the urgency relevant to avoid or reduce harm, (2) the likelihood of success of the diagnostic or therapeutic measure advised, and (3) the availability of alternative treatment options. In the event of a relevant risk of harm as a result of prioritization, these decisions should be made by means of a team approach. Gender, age, disability, ethnicity, origin, and other social characteristics, such as social or insurance status, as well as the vehemence of a patient's treatment request and SARS-CoV-2 vaccination status should not be used as prioritization criteria. The guideline provides concrete recommendations for (1) diagnostic procedures, (2) surgical procedures for cancer, and (3) systemic treatment and radiotherapy in patients with colorectal or pancreatic cancer within the context of the German healthcare system.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.20
自引率
0.00%
发文量
84
期刊介绍: With the first issue in 2014, the journal ''Onkologie'' has changed its title to ''Oncology Research and Treatment''. By this change, publisher and editor set the scene for the further development of this interdisciplinary journal. The English title makes it clear that the articles are published in English – a logical step for the journal, which is listed in all relevant international databases. For excellent manuscripts, a ''Fast Track'' was introduced: The review is carried out within 2 weeks; after acceptance the papers are published online within 14 days and immediately released as ''Editor’s Choice'' to provide the authors with maximum visibility of their results. Interesting case reports are published in the section ''Novel Insights from Clinical Practice'' which clearly highlights the scientific advances which the report presents.
期刊最新文献
Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma. A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors. EGFR plus MET targeted therapies for overcoming treatment resistance in EGFR mutant NSCLC. A Case Report. EGFR-TKI combined with radiotherapy in 105 patients of lung adenocarcinoma with brain metastasis: a retrospective study of prognostic factors analysis. Guidelines: onkopedia - what´s new? Locally advanced rectal cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1